WHO ICTRP trial
A Randomized, Blinded, Placebo-Controlled Phase I Clinical Trial to Evaluate the…
ChiCTR2500102203 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500102203 |
|---|---|
| Public title | A Randomized, Blinded, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of BW-201 (Adi1) in Healthy Adults Aged 18 Years and Older |
| Scientific title | A Randomized, Blinded, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of BW-201 (Adi1) in Healthy Adults Aged 18 Years and Older |
| Primary sponsor | Hebei Provincial Center for Disease Control and Prevention |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Lower Respiratory Tract Disease (LRTD) caused by Respiratory Syncytial Virus (RSV) |
| Interventions | BW-201 (Adj 1) low dose group:This product is administered once, 60ug. The antigen and adjuvant must be mixed prior to administration. The adjuvant vial should be inverted 5 to 10 times to mix thoroughly. The entire volume of the adjuvant… |
| Registration date | May 12, 2025 |
| Target size | BW-201 (Adj 1) low dose group:32; BW-201 (Adj 1) high dose group:32;Sodium… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: